ONO-2808 – S1P5 receptor agonist
Multiple system atrophy (MSA)
About This Program
ONO-2808, an investigational compound, is being investigated in a Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy in patients with MSA.
To learn more about this study, click here.